We have examined the expression of major histocompatibility complex (MHC) antigens, constitutive or induced with interferon gamma (IFN-y), in a line of C3H mouse embryo fibroblasts (C3H 2.01) transformed with a helper-virus-free preparation of the Kirsten strain of murine sarcoma virus. C3H201 cells expressed some class I antigen (H-2Kk) in the absence of added interferon, unlike the parental C3H lOT1/2 cells from which they were derived. However, this declined with (in vitro) passage level after transformation. Treatment with IFN-y induced very high expression of H-2Kk at all passage levels. There was no constitutive expression of class II antigen (I-Ak); however, this could be induced by IFN-y. Inducibility of I-Ak was found also to be related to the number of passages after transformation; at early passage levels after transformation more I-Ak was induced than after the cells had been allowed to grow for several passages, until at high passage levels little or no I-Ak was induced. This was not due to the presence of a subpopulation of untransformed cells since when the cells were cloned shortly after infection all the resulting clones were transformed. In addition, IFN-y at any passage level induced clearly less I-Ak than was found in C3H lOT1/2 cells, in which I-Ak inducibility was high and stable. Twenty-one clones were derived from C3H 201 cells at early passage (<8) either from soft agar or from liquid culture. These clones showed a wide variation in MHC antigen phenotype. Many expressed H-2Kk in the absence of IFN-y, and all were strongly inducible for H-2Kk. None showed I-Ak in the absence of IFN-y. All but two expressed I-Ak after IFN-y treatment but, with four exceptions, clearly less than the untransformed line. Four clones derived at late passage (40) resembled the late passage line. The expression of the ras oncogene and tumorigenicity was studied in representative clones; there was no obvious correlation with MHC phenotype, nor with the method of cloning. We conclude from these studies that the expression of MHC antigens by fibroblasts expressing the vKi-ras oncogene, either with or without exposure to interferon gamma, is unstable, varying with the number of cell generations from transformation and from clone to clone.
There is accumulating evidence that (at least in experimental systems) the ability of a tumour to grow in a syngeneic host is governed by the density of major histocompatibility complex (MHC) antigens on the surface of the tumour cell (Goodenow et al., 1985) . This is reflected in the finding, for example, that transfecting MHC antigen genes into an MHC antigen negative tumour line (so that it becomes antigen positive) drastically reduces its tumorigenicity (Hui et al., 1984; Tanaka et al., 1985; Wallich et al., 1985) . The implication of this is that the T cell branch of the immune system is in somne way important in the control of tumour growth, although it is of course possible that some other feature of MHC antigen biology may be involved.
In many cell types the expression of MHC antigens is inducible, with the interferons (IFNs) being the principle factors responsible for this induction, although other cytokines may act as cofactors, either augmenting (e.g. tumour necrosis factor together with IFN-gamma (IFN-y) in the induction of class II MHC: Lapierre et al. (1988) ) or reducing (e.g. transforming growth factor together with IFNy in the induction of class II : Czarniecki et al. (1988) ) MHC antigen induction. It follows that in any study of the relationship between MHC antigen phenotype and tumorigenicity of cells both constitutive and induced MHC antigen expression should be taken into account. We have previously noted that in a line of C3H mouse embryo fibroblasts (C3H lOT1/2) the expression of the v-Ki-ras oncogene influences the way in which MHC antigens are expressed (Maudsley & Morris, 1988) . The fibroblasts were infected with a helpervirus-free preparation of the Kirsten strain of murine sarcoma virus (MSV) to generate a line of cells (C3H 201) which is malignantly transformed, forming tumours at the site of inoculation in syngeneic C3H mice. These transformed cells when treated with IFN-y express much reduced levels of MHC class II antigens compared with the parental, untransformed fibroblasts which after IFN-y treatment express high levels of these antigens.
Here we report a further investigation of this phenomenon. The use of helper-virus-free MSV has allowed us to introduce the v-Ki-ras oncogene with high efficiency into cells so that we are able to study events very soon after the transformation of the bulk culture. Alternative techniques would not permit this; transfection with viral DNA is very inefficient, and infection with standard virus preparations would introduce complexities due to the inevitable presence of the helper leukaemia virus. We have found that the expression of MHC antigens by the transformed cells varies with the passage level after transformation. In a series of clones prepared from the infected line, which were all clearly transformed at least by morphological criteria, there was wide variation in the constitutive and induced expression of MHC antigens. The implication is that MHC antigen expression in these ras transformed cells is unstable; this may contribute to the evolution of such tumours, with selection occurring for variants which express low levels of MHC antigen, either constitutive or induced.
Materials and methods
Cells and tissue culture techniques C3H 1OTl/2 cells (Reznikoff et al., 1973) and their MSVtransformed derivative C3H 201 (Maudsley & Morris, 1988) were maintained in the Glasgow modification of Eagle's minimal essential medium supplemented with 10% fetal calf serum, subculturing as soon as confluent at a 1:8 ratio (i.e. approximately three cell generations per subculture). Cloning of C3H 201 cells was done either from liquid medium or from soft agar. In the former case, cells were distributed into microtitre trays at 1 or 0.3 cells per well in 200 p1 of medium. After 1 week, the tray was scanned and wells containing single colonies were selected. The medium was changed weekly in these wells and colonies subcultured by trypsinisation when large enough. Cloning efficiency under these conditions was close to 100% for both C3H 10T1/2 and C3H 201 so the technique is not selective for cells with the transformed phenotype. For soft agar cloning, 5ml aliquots of culture medium containing 20% fetal calf serum and 0.4% agar were placed in 5cm Petri dishes and left to harden. Subsequently duplicate l ml aliquots of medium (20% serum, 0.3% agar) containing either 100 or 1,000 cells were added. After 10-14 days, large, well-separated colonies were picked with Pasteur pipettes and placed in liquid culture. This technique selects cells with the transformed phenotype and C3H 10T1/2 cells will not grow; the cloning efficiency of C3H 201 cells under these conditions varies with passage level (see Results).
To estimate cloning efficiency in soft agar, the numbers of cells in 20 low power microscope fields of each dish were counted immediately after plating; 10 days later the numbers of large colonies in the same number of fields were counted so that the number of colonies formed per cell plated could be directly calculated. This method can only give an approximate measure of cloning efficiency because, especially at the early passages of C3H 201, many small and intermediate-sized colonies were formed, which made the counting uncertain.
For IFN treatment of cells, cultures were treated with a preparation of recombinant (r-)IFN-y from transfected CHO cells (Morris & Ward, 1988 ) at a final concentration of 100luml-1.
Estimation of ras mRNA and p21 protein The amounts of ras mRNA in cells was determined by dot blot hybridisation (Siggens, 1988) , probing filters dotted with aliquots of RNA prepared from cells with a 32p labelled fragment of a cDNA clone (Norton et al., 1984) of the same MSV used for transformation, quantitating the extent of hybridisation by liquid scintillation counting of cut-out pieces of the filter. The p21 protein product was estimated by Western blotting. Proteins from cells lysed with 2% NP40 were separated electrophoretically, loading equal weights of protein on to 10% acrylamide gels. After transfer to nitrocellulose filters, ras p21 was visualised using a specific monoclonal antibody (National Cancer Institute, Bethesda, MD, USA) followed successively by biotinylated sheep antimouse Ig serum and streptavidin-biotinylated horseradish peroxidase (both from Amersham International plc, UK). The colour reagent used as substrate for the enzyme was 4-chloro-l-naphthol (Biorad Laboratories).
Tumorigenicity of cells Aliquots of 106 cells were inoculated subcutaneously into the hind legs of 6-8-week-old C3H-He mice from the breeding colony maintained at this department. The mice were inspected and palpated over a 6-week period. Tumours usually appeared at the site of injection within 7-10 days.
Measurement of MHC antigen on cells Cells were stained as previously described (Maudsley & Morris, 1988) Expression of ras by selected clones Although all the clones isolated were morphologically transformed, we confirmed the expression of ras in representative clones by detecting mRNA and the p21 protein product. RNA was prepared from seven clones (367V, 368D and K, 396A, E, F and G) and probed for the presence of ras mRNA, which was detected in all cases at above background levels found for C3H 10T1/2 cells. Data for the four clones in Figure 2 are shown in Table III together with equivalent data for C3H 10T1/2 and C3H 201. An explanation for the presence of class II inducible cells was that there was a persisting sub-population of cells which had not been infected with the MSV. The persistence of a population of untransformed cells is implied by the lower plating efficiency in soft agar of the early-passage line. However, an alternative explanation is that (as we have previously shown (Morris, 1981) ), the transformed phenotype does not fully develop in C3H 10T1/2 cells until some time after infection with MSV. Hence we prepared clones from the line at an early passage level in the expectation that some would be untransformed. None were, at least by morphology, and although we cannot exclude that we unconsciously selected clones with transformed morphology, it became clear in the subsequent analysis of the clones' properties that high ras expressing clones were inducible for class II antigens. Hence the mere expression of ras does not in itself abrogate class II induction.
Our data imply that variations in the inducibility of class II antigens do not greatly affect the development of tumours, since there is apparently no correlation of class II inducibility with tumorigenicity; for example 396A, which is strongly inducible, appears about as tumorigenic as 368D, which is not inducible. Two clones which were very much less tumorigenic than the others were notable in that they expressed high levels of H-2Kk in the absence of IFN. It may be that the constitutive expression of class I antigen is a major determinant of tumorigenicity in this system; in which case, to study a potential role for induced class II antigens we should choose class I-negative clones and determine whether there is then a correlation of class II inducibility with lower tumorigenicity. An alternative strategy that we are currently pursuing is to sort (by fluorescence activated cell sorter) sublines which differ in their inducibility for class II but otherwise have similar MHC phenotypes (Morris et al., 1989) ; these in preliminary experiments do appear to differ in their tumorigenicity, with the more inducible subline being less tumorigenic. Of course, there must be many factors which influence the ability of cells expressing activated ras to grow as a tumour, and it is at present impossible to determine whether instability of MHC antigen expression, either constitutive or induced, is of decisive importance. However, it is a factor which needs to be taken into account when considering how tumours may 'escape' from mechanisms of host control of tumour growth.
